CAMKK2 and epilepsy: Using a subset of data from the Cancer Genome Atlas (TCGA) [11] consisting of mRNA expression data of surgical specimens from 24 glioblastoma patients, and 10 non-tumor control brains (epilepsy resections), we confirmed the lower mRNA expression of CAMKK2 in high-grade glioma (Fig 4D).